贵州三力：悦欣医药减持0.1976%

Group 1 - The major shareholder, Hainan Yuexin Pharmaceutical Investment Partnership (General Partnership), has completed its share reduction plan, selling 809,900 shares of Guizhou Sanli, which accounts for 0.1976% of the total share capital [1] - After the reduction, the major shareholder holds 20,190,100 shares, representing 4.9268% of the total shares [1] - The initial plan was to reduce holdings by up to 2,049,000 shares, which would have represented 0.5000% of the total share capital [1]